Detalhe da pesquisa
1.
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity.
Nat Immunol
; 21(8): 914-926, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424363
2.
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy.
Nature
; 629(8010): 201-210, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600376
3.
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors.
Mol Ther
; 28(11): 2379-2393, 2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735774
4.
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Cell Rep
; 42(8): 113014, 2023 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605534
5.
A2AR eGFP reporter mouse enables elucidation of A2AR expression dynamics during anti-tumor immune responses.
Nat Commun
; 14(1): 6990, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914685
6.
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
Nat Commun
; 12(1): 3236, 2021 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050151
7.
MAIT cells regulate NK cell-mediated tumor immunity.
Nat Commun
; 12(1): 4746, 2021 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34362900
8.
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
Clin Cancer Res
; 26(2): 487-504, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31636098
9.
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Cell Rep
; 43(2): 113793, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324452